OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH

Saved in:
Bibliographic Details
Published inDigestive and liver disease Vol. 51; p. e101
Main Authors Buda, A., Facchin, S., Lorenzon, G., Barberio, B., Zingone, F., Savarino, E., D'Incà, R.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 25.03.2019
Online AccessGet full text

Cover

Loading…
Author Buda, A.
Barberio, B.
Zingone, F.
Lorenzon, G.
Savarino, E.
Facchin, S.
D'Incà, R.
Author_xml – sequence: 1
  givenname: A.
  surname: Buda
  fullname: Buda, A.
– sequence: 2
  givenname: S.
  surname: Facchin
  fullname: Facchin, S.
– sequence: 3
  givenname: G.
  surname: Lorenzon
  fullname: Lorenzon, G.
– sequence: 4
  givenname: B.
  surname: Barberio
  fullname: Barberio, B.
– sequence: 5
  givenname: F.
  surname: Zingone
  fullname: Zingone, F.
– sequence: 6
  givenname: E.
  surname: Savarino
  fullname: Savarino, E.
– sequence: 7
  givenname: R.
  surname: D'Incà
  fullname: D'Incà, R.
BookMark eNqFkdGKnDAYhaVsobvbPkIhlzMXzibRRO1NyWjGCUQjJrLtVZh1IljamUVLoc_dF9jotte9Ssh_zvcfcu6Cm8v14oLgI4I7BBF90IhkMEwpSTco20YQpSTM3gS3KE3SMCIU3_j7P8m74G6ev0GIESXwNvij8h3MdhEQ9UGKL6Jie1AozcOWF11uhKr9ZB2yqmJGtV_BXj1yCQqhOdMcbMS-2IKGGcFroxdx0yqp6pIXoOC8AS2vhNYe9Ak0yniRYBKIqpEiZwtfA7-j4CHXOZPrC9CmZYaXgq885hHeIsWBg1yK2vsk0NwYUZfgUZij6owXmSNvWcM7I3JQtF0JKlULH3hRbUxRbQFrfDSWH98Hb4fT99l9-HveB92Bm_wYSlUu8LBHEGchdiihFMNswMNpeKKJi3ucDgjH5xNMSNbjhFAaDZAQHMcI-x-OCB5cGj3FNIqT6D4gr9x-us7z5Ab7PI0_TtNvi6BdmrNrc3apxaLMrs3ZzPs-v_qcD_drdJOd-9FdenceJ9f_tOfr-B_CC_e5jn8
ContentType Journal Article
Copyright 2019 Editrice Gastroenterologica Italiana S.r.l. All rights reserved.
Copyright_xml – notice: 2019 Editrice Gastroenterologica Italiana S.r.l. All rights reserved.
DBID AAYXX
CITATION
DOI 10.1016/S1590-8658(19)30185-9
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1878-3562
EndPage e101
ExternalDocumentID 10_1016_S1590_8658_19_30185_9
S1590865819301859
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABJNI
ABLVK
ABMAC
ABMZM
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AEVXI
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FD8
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
IHE
J1W
KOM
LCYCR
M41
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
Z5R
~G-
AAQXK
AAXKI
AAYXX
ABFNM
ABXDB
ADMUD
AFJKZ
AKRWK
ASPBG
AVWKF
AZFZN
CITATION
FGOYB
HZ~
R2-
SEW
ID FETCH-LOGICAL-c1029-2e1766209f2fafb67e4c28f124da0759c275663f05524412590352fe83b463473
IEDL.DBID AIKHN
ISSN 1590-8658
IngestDate Thu Sep 26 18:41:45 EDT 2024
Fri Feb 23 02:26:58 EST 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1029-2e1766209f2fafb67e4c28f124da0759c275663f05524412590352fe83b463473
ParticipantIDs crossref_primary_10_1016_S1590_8658_19_30185_9
elsevier_sciencedirect_doi_10_1016_S1590_8658_19_30185_9
PublicationCentury 2000
PublicationDate 2019-03-25
PublicationDateYYYYMMDD 2019-03-25
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-25
  day: 25
PublicationDecade 2010
PublicationTitle Digestive and liver disease
PublicationYear 2019
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0021650
Score 2.2724106
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage e101
Title OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH
URI https://dx.doi.org/10.1016/S1590-8658(19)30185-9
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZ2uxLigmAXxPJYzQGh9pBt3q25uYnbGPJS4mjLKUrTRNoDZYWWAxf-NH-AsZsWkBAHrvbMxMqMZj7b4xlC3rToFhGYowYcrzVcukE_6Nszo6Wu77R915i6nU-S-lHlvl976xMSHN7CqLTKwffvfbr21sPIdPib07vb22lpqXbdGEARgpgYdegpOcNw5LojcsbEhyg97rssXzdqVfSGYvj1kGcvRA-OLTrRcgz69xD1W9hZPiaPBrwIbL-kJ-Sk252TC7bDvfKnb_AWdAanPho_Jw-S4aL8gvzIAlVY1QGRLmOxFglbQJiV3ChUqx11LIUzepIlCZNZ8REW2Q2PIRQlZyWHsViEE8iZFDyVpSLOiyzO0hUPIeQ8hwIVqD3xO8gziUSCxSCS_Pg0GfAbITd4GbBYj4Dqzyz5CgGoksdQBLLEYskhiEWqCjNAyaUU6QpuhIyySiKRjHjBcl5JEUBYVCvAICBwwYpqLMNkAizHpbEgekqqJZdBZAz9HYzWUlk3dqeqU9om7e2-6Tf-rHNbe94j4tg2iGRoq0rT-05veh6CEERiVBVv7bu5s0FDcmfOMzLafd51zwlQd-uhr5q3zgYBoCqT3zqN17sOytya8-aSXB9UWt_ty3jUx_w2ZQO1soHaorW2gZpekvlB8fUf9lhjqPk364v_Z31JHiIgoyrHzfZekdH9l6_dawQ995srcnr93boaTPsnB0vmCQ
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuCHZBLM85INQesm3zas3NTdzGkJcSV9s9RW2aSHugu1otBy78af4AM25aQEIcuNrjieUZzXxJxt8w9r7GsIjAHC3geLXl8jXGQd8eWzV3fadum9XQtPNJUj9auJ-W3vKIBfu7MFRW2cX-XUw30bobGXSnObi5uhqUI2rXjQkUIcgQsw6_x-4TGqC6rvPvhzoPe-SbNq0kbZH4r2s8OxVmsDfifaPF4n9PUL8lndkT9rhDiyB2G3rKjprtCTsVW3xT_vINPoCp3zQfxk_Yg6T7TX7KfmQB0ao6oNJZrJYqEVMIs1JaBTXaoY9SOGMmRZIInRWXMM0uZAyhKqUoJfTUNOxDLrSSqS5JOC-yOEvnMoRQyhwKNJ-Jwx8hzzQKKRGDSvLDxWTAZ4TSkmUgYjMC1J1ZyznCT9InUAUuidVMQhCrlGgZoJRaq3QOF0pH2UKjkI5kIXK50CqAsFjMAVOAwg2TVE-HSR9EjlsTQfSMLWZSB5HVdXew6hHV3NgNcVPaQ97a7apd--PGre1Ji3hjs0Icw2sipvedduh5CEEQh3Gibm2bibNGN3LHznN2vL3eNi8YcHfjYaSa1M4a4R-R5NfOymtdB3VuhpPVGTvfm7S62ZF4VIfqNvKBinygGvHK-EDFz9hkb_jqD2-sMNH8e-nL_1_6jj2MdBJXeOifX7FHCM04VbvZ3mt2fHf7tXmD8Odu_da490_nvebe
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=OC.09.3+INFLIXIMAB+DOSE-REDUCTION+IN+INFLAMMATORY+BOWEL+DISEASE+%28IBD%29+PATIENTS+IN+PROLONGED+DEEP+REMISSION%3A+POTENTIAL+IMPLICATIONS+ON+DE-ESCALATION+STRATEGIES+IN+A+REAL+LIFE+CLINICAL+SETTING+WITHOUT+A+THERAPEUTIC+DRUG+MONITORING+%28TDM%29+APPROACH&rft.jtitle=Digestive+and+liver+disease&rft.au=Buda%2C+A.&rft.au=Facchin%2C+S.&rft.au=Lorenzon%2C+G.&rft.au=Barberio%2C+B.&rft.date=2019-03-25&rft.pub=Elsevier+Ltd&rft.issn=1590-8658&rft.eissn=1878-3562&rft.volume=51&rft.spage=e101&rft.epage=e101&rft_id=info:doi/10.1016%2FS1590-8658%2819%2930185-9&rft.externalDocID=S1590865819301859
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1590-8658&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1590-8658&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1590-8658&client=summon